Cargando…
Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes
Patients with type 2 diabetes mellitus have a twofold increased risk of cardiovascular mortality compared with non-diabetic individuals. There is a growing awareness that glycemic efficacy of anti-diabetic drugs does not necessarily translate to cardiovascular safety. Over the past few years, there...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288947/ https://www.ncbi.nlm.nih.gov/pubmed/28148253 http://dx.doi.org/10.1186/s12933-017-0499-5 |